LGT Capital has now backed two of the largest GP-led deals in Asia this year, having participated in IDG Capital’s yuan-to-dollar restructuring in September.
2 min read · 09 December 2020
Demand among buyers and LPs’ desire to manage their portfolios in the wake of covid-19 point to healthy transaction secondaries volumes in the year ahead.
3 min read · 09 December 2020
The chairman of BC Partners’ investment committee had previously said that single-asset deals and cross fund transactions were ‘not worth the headache’.
2 min read · 08 December 2020
ICG underwrote nearly half the transaction on Curium Pharma, an asset described as ‘cream of the crop’ by one secondaries buyer.
2 min read · 02 December 2020
Sellers pushed on with secondaries sales despite the crisis and dealflow is likely to remain strong into December, according to Jared Barlow, a partner at the firm.
2 min read · 01 December 2020
The firm, which last week closed the sale of a minority stake in Pensions Insurance Corporation to a UK family office, will begin marketing Keyhaven Secondaries Fund III next year.
2 min read · 30 November 2020
Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.
2 min read · 26 November 2020
The rise of GP-led deals has highlighted the importance of liability protection, bringing warranty & indemnity insurance into the secondary market, say insurance broker Lockton and law firm Akin Gump.
4 min read · 25 November 2020
The flight towards high-quality assets is ongoing as buyers wait for clarity on the real economic impact of covid-19, according to Jasmin Capital’s head of secondaries.
2 min read · 23 November 2020
Buyers who have shown interest so far include some traditional secondaries firms, sovereign wealth funds and insurance companies.
3 min read · 17 November 2020
